Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

Experimental Hematology

Volumn 28, Issue 7, 2000, Pages 853-857

  Slavin, Shimon ^a   Nagler, Arnon ^a   Varadi, Gabor ^a   Or, Reuven ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Chronic myelogenous leukemia; Graft vs autoimmunity; Mini transplant; Non myeloablative stem cell transplantation; Psoriatic arthritis

Indexed keywords

BCR ABL PROTEIN; BUSULFAN; CYCLOSPORIN A; DNA; FLUDARABINE; LYMPHOCYTE ANTIBODY; METHOTREXATE;

ADULT; ALLOGRAFT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; LYMPHOCYTE; MALE; MITOSIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ADULT; ANTINEOPLASTIC AGENTS; ARTHRITIS, PSORIATIC; AUTOIMMUNITY; BUSULFAN; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTES; MALE; PSORIASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIDARABINE;

ANIMALIA;

EID: 0034131058     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00172-7     Document Type: Article

References (32)

1. Karussis D.M., Slavin S., Ben-Nun A.et al. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE). Treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation J Neuroimmunol. 39:1995;201.
2. Karussis D.M., Slavin S., Lehmann D., Mizrachi-Koll R., Abramsky O., Ben-Nun A. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol. 148(6):1992;1693.
3. Karussis D.M., Vourka-Karussis U., Ovadia H.et al. Prevention and reversal of adoptively transferred chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE) with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J Clin Invest. 92(2):1993;765.
4. Slavin S. Treatment of life threatening autoimmune diseases with myeloablative doses of immunosuppressive agents and autologous bone marrow transplantation - Rationale and experimental background. Bone Marrow Transplant. 12:1993;85.
5. Van Bekkum DW Review BMT in experimental autoimmune diseases. Bone Marrow Transplant. 11:1993;183.
6. Ikehara S. The prospects for BMT-from mouse to human. Ikehara S., Takaku F., Good R.A. Bone Marrow Transplantation. Basic and Clinical Studies. 1996;Springer, Tokyo-Singapore. 302p.
7. Moscovitch M., Slavin S. Regulation of the immune response in experimental models of autoimmune disorders. 1. Immunocompetence and transplantation tolerance in (NZB × NZW)F1 hybrid mice immunosuppressed with total lymphoid irradiation and in reconstituted bone marrow chimeras. J Clin Lab Immunol. 4:1983;185.
8. Slavin S. Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation. Proc Natl Acad Sci USA. 76:1979;5274.
9. Moscovitch M., Rosenmann E., Neeman Z., Slavin S. Successful treatment of autoimmune manifestations in MRL/1 and MRL/n mice using total lymphoid irradiation (TLI). Exp Molec Pathol. 38:1983;33.
10. Slavin S. Treatment of life threatening autoimmune diseases with myeloablative doses of immunosuppressive agents and autologous bone marrow transplantation - Rationale and experimental background. Bone Marrow Transplant. 2:1993;85.
11. Kappler J.E., Staerz U.D., White J., Marrack P. Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex. Nature. 332:1988;35.
12. Morecki S., Leshem B., Eid A., Slavin S. Alloantigen persistence in induction and maintenance of transplantation tolerance. J Exp Med. 165:1987;1468.
13. Slavin S., Strober S., Fuks Z., Kaplan H.S. Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science. 193:1976;1252.
14. Slavin S. Total lymphoid irradiation (TLI). Immunol Today. 8:1987;88.
15. Slavin S., Nagler A., Naparstek E.et al. Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood. 91(3):1998;756.
16. Slavin S., Naparstek E., Nagler A.et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse post allogeneic bone marrow transplantation. Blood. 87:1996;2195.
17. Kolb H.J., Schattenberg A., Goldman J.M. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 86:1995;2041.
18. Collins R.H., Shpilber O., Drobyski W.R.et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 15:1997;433.
19. Aker M., Kapelushnik J., Pugatsch T.et al. Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic BMT for beta thalassemia major. J of Pediatric Hematology/Oncology. 20(2):1998;145.
20. Fassas A., Anagnastopoulos A., Kazis A. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis. First results of a pilot study Bone Marrow Transplant. 20:1997;631.
21. Pugatsch T., Oppenheim A., Slavin S. Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT. Bone Marrow Transplantation. 17:1996;273.
22. Marmont A.M. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases. J Rheumatol. 24(Suppl 48):1997;1.
23. Giralt S., Estey E., Albitar M.et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy. Harnessing graft-vs-leukemia without myeloablative therapy Blood. 89:1997;4531.
24. Naparstek E., Or R., Nagler A.et al. T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. Brit J Haematol. 89:1995;506.
25. Odom L.F., August C.S., Githens J.H. Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man? Lancet. 2:1978;537.
26. Bacigalupo A., van Lint M.T., Occhini D.et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood. 77:1991;1423.
27. Ben-Yosef R., Or R., Nagler A., Slavin S. Graft vs tumor and graft vs leukemia in patient with concurrent breast cancer and acute myelocytic leukemia. Lancet. 348:1996;1242.
28. Morecki S., Moshel Y., Gelfend Y., Pugatsch T., Slavin S. Induction of graft vs tumor effect in a murine model of mammary adenocarcinoma. Int J Cancer. 71:1997;59.
29. Slavin S., Fuks Z., Kaplan H.S., Strober S. Transplantation of allogeneic bone marrow without graft vs host disease using total lymphoid irradiation. J Exp Med. 47:1978;963.
30. Reisner Y., Martelli M.F. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today. 16:1995;437.
31. Tyndall A., Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease (A consensus report). Brit J Rheumatology. 36:1997;390.
32. Bonini C., Ferrari G., Verzeletti S.et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft versus leukemia. Science. 276:1997;1719.